The anticipated offering value is about US$619 million (roughly 4.2 billion yuan), aligning with other outlets’ reporting.

Registration approval is not the final listing; a final share price and issuance date still need to be set, typically weeks after approval.

Unitree is among several Chinese humanoid robotics players pursuing capital markets, including AgiBot and EngineAI in Hong Kong, with others like Dobot and Leju Robotics weighing listings, shaping sector sentiment.

The company has cleared the Shanghai Stock Exchange's listing committee and is finalising underwriting, pricing, and subscriptions for a potential debut as soon as late July.

Unitree Robotics has won registration approval from China's CSRC to list on the Shanghai STAR Market, moving closer to an IPO pricing and launch.

Regulators have cleared the way for a Shanghai IPO, setting a potential valuation benchmark for China's embodied AI and robotics sector.

Valuation estimates for Unitree's listing range roughly from $5.9 billion to $7 billion, with a precise figure coming as underwriters set the offer price.

A peer, UBTech Robotics, posted last year revenue of about 2 billion yuan but a net loss near 700 million yuan, with a market cap around HK$52.8 billion (US$6.7 billion) at the time.

The humanoid robotics space faces a software-versus-hardware gap and fierce competition, with investors watching how software capabilities translate into real commercial viability beyond hardware demos.

Unitree aims to raise about 4.2 billion yuan (roughly US$618 million) by selling at least 40.4 million shares, implying an initial valuation around 42 billion yuan.

Proceeds are earmarked for robot models, body research, new products, and expanded manufacturing capacity to fuel growth.

Funds will also back software and control-system development (the 'brains' of the robots), new product lines, and increased production capacity amid a broader trend of humanoid robotics firms pursuing Chinese listings.